412 related articles for article (PubMed ID: 25582055)
1. Modulation of microRNA editing, expression and processing by ADAR2 deaminase in glioblastoma.
Tomaselli S; Galeano F; Alon S; Raho S; Galardi S; Polito VA; Presutti C; Vincenti S; Eisenberg E; Locatelli F; Gallo A
Genome Biol; 2015 Jan; 16(1):5. PubMed ID: 25582055
[TBL] [Abstract][Full Text] [Related]
2. ADAR2/miR-589-3p axis controls glioblastoma cell migration/invasion.
Cesarini V; Silvestris DA; Tassinari V; Tomaselli S; Alon S; Eisenberg E; Locatelli F; Gallo A
Nucleic Acids Res; 2018 Feb; 46(4):2045-2059. PubMed ID: 29267965
[TBL] [Abstract][Full Text] [Related]
3. A-to-I editing in human miRNAs is enriched in seed sequence, influenced by sequence contexts and significantly hypoedited in glioblastoma multiforme.
Paul D; Sinha AN; Ray A; Lal M; Nayak S; Sharma A; Mehani B; Mukherjee D; Laddha SV; Suri A; Sarkar C; Mukhopadhyay A
Sci Rep; 2017 May; 7(1):2466. PubMed ID: 28550310
[TBL] [Abstract][Full Text] [Related]
4. ADAR2 induces reproducible changes in sequence and abundance of mature microRNAs in the mouse brain.
Vesely C; Tauber S; Sedlazeck FJ; Tajaddod M; von Haeseler A; Jantsch MF
Nucleic Acids Res; 2014 Oct; 42(19):12155-68. PubMed ID: 25260591
[TBL] [Abstract][Full Text] [Related]
5. Adenosine Deaminase That Acts on RNA 3 (ADAR3) Binding to Glutamate Receptor Subunit B Pre-mRNA Inhibits RNA Editing in Glioblastoma.
Oakes E; Anderson A; Cohen-Gadol A; Hundley HA
J Biol Chem; 2017 Mar; 292(10):4326-4335. PubMed ID: 28167531
[TBL] [Abstract][Full Text] [Related]
6. ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis.
Galeano F; Rossetti C; Tomaselli S; Cifaldi L; Lezzerini M; Pezzullo M; Boldrini R; Massimi L; Di Rocco CM; Locatelli F; Gallo A
Oncogene; 2013 Feb; 32(8):998-1009. PubMed ID: 22525274
[TBL] [Abstract][Full Text] [Related]
7. Base-pairing probability in the microRNA stem region affects the binding and editing specificity of human A-to-I editing enzymes ADAR1-p110 and ADAR2.
Ishiguro S; Galipon J; Ishii R; Suzuki Y; Kondo S; Okada-Hatakeyama M; Tomita M; Ui-Tei K
RNA Biol; 2018; 15(7):976-989. PubMed ID: 29950133
[TBL] [Abstract][Full Text] [Related]
8. ADAR1- and ADAR2-mediated regulation of maturation and targeting of miR-376b to modulate GABA neurotransmitter catabolism.
Widmark A; Sagredo EA; Karlström V; Behm M; Biryukova I; Friedländer MR; Daniel C; Öhman M
J Biol Chem; 2022 Mar; 298(3):101682. PubMed ID: 35124003
[TBL] [Abstract][Full Text] [Related]
9. Adenosine deaminases that act on RNA induce reproducible changes in abundance and sequence of embryonic miRNAs.
Vesely C; Tauber S; Sedlazeck FJ; von Haeseler A; Jantsch MF
Genome Res; 2012 Aug; 22(8):1468-76. PubMed ID: 22310477
[TBL] [Abstract][Full Text] [Related]
10. Modulation of microRNA processing and expression through RNA editing by ADAR deaminases.
Yang W; Chendrimada TP; Wang Q; Higuchi M; Seeburg PH; Shiekhattar R; Nishikura K
Nat Struct Mol Biol; 2006 Jan; 13(1):13-21. PubMed ID: 16369484
[TBL] [Abstract][Full Text] [Related]
11. A comparative analysis of ADAR mutant mice reveals site-specific regulation of RNA editing.
Costa Cruz PH; Kato Y; Nakahama T; Shibuya T; Kawahara Y
RNA; 2020 Apr; 26(4):454-469. PubMed ID: 31941663
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of RNA editing in pediatric astrocytomas: ADAR2 editing activity inhibits cell migration and proliferation.
Cenci C; Barzotti R; Galeano F; Corbelli S; Rota R; Massimi L; Di Rocco C; O'Connell MA; Gallo A
J Biol Chem; 2008 Mar; 283(11):7251-60. PubMed ID: 18178553
[TBL] [Abstract][Full Text] [Related]
13. ADAR2-mediated editing of miR-214 and miR-122 precursor and antisense RNA transcripts in liver cancers.
Liu WH; Chen CH; Yeh KH; Li CL; Wu YJ; Chen DS; Chen PJ; Yeh SH
PLoS One; 2013; 8(12):e81922. PubMed ID: 24386085
[TBL] [Abstract][Full Text] [Related]
14. ADAR2 editing activity in newly diagnosed versus relapsed pediatric high-grade astrocytomas.
Tomaselli S; Galeano F; Massimi L; Di Rocco C; Lauriola L; Mastronuzzi A; Locatelli F; Gallo A
BMC Cancer; 2013 May; 13():255. PubMed ID: 23697632
[TBL] [Abstract][Full Text] [Related]
15. Abnormal expression of an ADAR2 alternative splicing variant in gliomas downregulates adenosine-to-inosine RNA editing.
Wei J; Li Z; Du C; Qi B; Zhao X; Wang L; Bi L; Wang G; Zhang X; Su X; Pan Y; Tian Y
Acta Neurochir (Wien); 2014 Jun; 156(6):1135-42. PubMed ID: 24509948
[TBL] [Abstract][Full Text] [Related]
16. Adenosine-to-Inosine RNA Editing Enzyme ADAR and microRNAs.
Yuting K; Ding D; Iizasa H
Methods Mol Biol; 2021; 2181():83-95. PubMed ID: 32729076
[TBL] [Abstract][Full Text] [Related]
17. ADAR2 Protein Is Associated with Overall Survival in GBM Patients and Its Decrease Triggers the Anchorage-Independent Cell Growth Signature.
Cesarini V; Silvestris DA; Galeano F; Tassinari V; Martini M; Locatelli F; Gallo A
Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36009036
[TBL] [Abstract][Full Text] [Related]
18. Expression level of miRNAs on chromosome 14q32.31 region correlates with tumor aggressiveness and survival of glioblastoma patients.
Shahar T; Granit A; Zrihan D; Canello T; Charbit H; Einstein O; Rozovski U; Elgavish S; Ram Z; Siegal T; Lavon I
J Neurooncol; 2016 Dec; 130(3):413-422. PubMed ID: 27573219
[TBL] [Abstract][Full Text] [Related]
19. The Role of ADAR1 and ADAR2 in the Regulation of miRNA-21 in Idiopathic Pulmonary Fibrosis.
Díaz-Piña G; Ordoñez-Razo RM; Montes E; Páramo I; Becerril C; Salgado A; Santibañez-Salgado JA; Maldonado M; Ruiz V
Lung; 2018 Aug; 196(4):393-400. PubMed ID: 29637273
[TBL] [Abstract][Full Text] [Related]
20. Modulation of ADAR mRNA expression in patients with congenital heart defects.
Altaf F; Vesely C; Sheikh AM; Munir R; Shah STA; Tariq A
PLoS One; 2019; 14(4):e0200968. PubMed ID: 31039163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
